3SBio Inc (1530)

Currency in HKD
29.86
-0.24(-0.80%)
Closed·
1530 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
1530 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.5430.60
52 wk Range
5.4734.20
Key Statistics
Bid/Ask
29.84 / 29.86
Prev. Close
30.1
Open
29.8
Day's Range
29.54-30.6
52 wk Range
5.47-34.2
Volume
31.87M
Average Volume (3m)
54.81M
1-Year Change
379.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1530 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.79
Downside
-0.23%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

3SBio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

3SBio Inc Company Profile

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; and Cipterbin, an anti-HER2 monoclonal antibody for the treatment of advanced HER2-positive breast cancer and pan-HER2. It also offers Yisaipu, the receptor fusion tumor necrosis factor inhibitor; EPIAO and SEPO, an erythropoietin injection; Mandi-minoxidil, an OTC external medicine for treating hair loss; and SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides Remitch, a nalfuraphine hydrochloride orally disintegrating tablets; MN709, a minoxidil foam formulation for the treatment of androgenetic alopecia and alopecia areata; and other products in the areas of nephrology, hematology, oncology, auto-immune, ophthalmology, and dermatology and metabolism. Further, it engages in trading; research and development of biotechnology and drugs; sells chemical products; and retail of pharmaceuticals. Additionally, the company provides project management and consultation, technology, sports, financial, clinic, investment advisory, and agricultural services, as well as manufactures medical devices. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People’s Republic of China.

Employees
5577
Market
Hong Kong

Compare 1530 to Peers and Sector

Metrics to compare
1530
Peers
Sector
Relationship
P/E Ratio
31.3x39.3x−0.5x
PEG Ratio
0.870.480.00
Price/Book
4.2x2.5x2.6x
Price / LTM Sales
7.2x6.9x3.3x
Upside (Analyst Target)
−13.7%3.6%43.5%
Fair Value Upside
Unlock8.8%6.8%Unlock

Analyst Ratings

12 Buy
1 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.79
(-0.23% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.86%
Dividend Yield
0.84%
Industry Median 2.41%
Annualised payout
0.25
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.40 / --
Revenue / Forecast
4.72B / 8.634B
EPS Revisions
Last 90 days

1530 Income Statement

People Also Watch

111.20
1211
-1.42%
278.00
9992
-0.29%
120.80
3690
-0.98%
91.25
1801
-0.16%

FAQ

What Stock Exchange Does 3SBio Trade On?

3SBio is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for 3SBio?

The stock symbol for 3SBio is "1530."

What Is the 3SBio Market Cap?

As of today, 3SBio market cap is 71.42B.

What Is 3SBio's Earnings Per Share (TTM)?

The 3SBio EPS (TTM) is 0.86.

From a Technical Analysis Perspective, Is 1530 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has 3SBio Stock Split?

3SBio has split 0 times.

How Many Employees Does 3SBio Have?

3SBio has 5577 employees.

What is the current trading status of 3SBio (1530)?

As of 09 Aug 2025, 3SBio (1530) is trading at a price of 29.86, with a previous close of 30.10. The stock has fluctuated within a day range of 29.54 to 30.60, while its 52-week range spans from 5.47 to 34.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.